Eksempler på brug af Or distribution på Spansk og deres oversættelser til Dansk
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.
EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.(44-20) 74 18 84 00 Fax(44-20) 74 18 86 68 E-mail: mail@emea. eu. int http://www. emea. eu. int© EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 86 68 E- mail: mail@ emea. eu. int http:// www. emea. eu. int© EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged* Bemærkninger.EMEA 2006 Reproduction and/ or distribution of this document is authorised for non-commercial purposes only provided the EMEA is acknowledged Contenido Introducción del Director Ejecutivo.
EMEA 2006 Reproduction and/ or distribution of this document is authorised for non- commercial purposes only provided the EMEA is acknowledged Indhold Indledning ved eksekutivdirektøren.(44-20) 74 18 84 00 Fax(44-20) 74 18 86 68 E-mail: mail@emea. eudra. org http://www. eudra. org/ emea. html EMEA 2005 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Notas.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 86 68 E- mail: mail@ emea. eudra. org http:// www. eudra. org/ emea. html EMEA 2005 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Bemærkninger.(44-20) 74 18 84 00 Fax(44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http://www. emea. europa. eu©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged el paciente tenía algún dolor y era capaz de cargar peso sobre la tibia, y si había o no necesidad de aplicar algún otro tratamiento a la tibia fracturada.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged patienten havde smerter og var i stand til at belaste skinnebenet; og på, hvorvidt der var behov for yderligere behandling af det brækkede skinneben.(44-20) 74 18 84 00 Fax(44-20) 74 18 84 09 E-mail: mail@emea. europa. eu www. emea. europa.eu©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non-commercial purposes only provided the EMEA is acknowledged Contenido INTRODUCCIÓN DEL DIRECTOR EJECUTIVO… 3.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 09 E- mail: mail@ emea. europa. eu www. emea. europa.eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non- commercial purposes only provided the EMEA is acknowledged Indhold Indledning ved den administrerende direktør… 3.(44-20) 74 18 84 00 Fax(44-20) 74 18 84 16 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged¿Qué tipo de estudios se han realizado sobre BeneFIX?
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. eu. int http:// www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Hvordan er BeneFIX blevet undersøgt?(44-20) 74 18 84 00 Fax(44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http://www. emea. europa. eu©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged entre los efectos de OPATANOL y los del placebo.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged var der mellem virkningen af OPATANOL og af placebo.(44-20) 74 18 84 00 Fax(44-20) 75 23 71 29 E-mail: mail@emea. europa. eu http://www. emea. europa. eu©EMEA 2008 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged El CHMP puede tardar hasta 210 días en evaluar una nueva solicitud.
(44- 20) 74 18 84 00 Fax(44- 20) 75 23 71 29 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2008 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged giver sin mening til kende.(44-20) 74 18 84 00 Fax(44-20) 74 18 84 47 E-mail: mail@emea. europa. eu http://www. emea. europa. eu©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged¿Qué tipo de estudios se han realizado con Locatim?
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 47 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Hvilken fordel viser undersøgelserne, der er ved Locatim?(44-20) 74 18 84 00, Fax(44-20) 74 18 84 16 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged¿Qué beneficios ha demostrado Tygacil durante dichos estudios?
(44- 20) 74 18 84 00, Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. eu. int http:// www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Hvilken gavnlig virkning har Tygacil vist i disse forsøg?(44-20) 74 18 84 00 Fax(44-20) 74 18 86 68 E-mail: mail@emea. eu. int http://www. emea. eu. int EMEA 2005 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged La lista de nombres del producto concernidos figura en el Anexo I.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 86 68 E- mail: mail@ emea. eu. int http:// www. emea. eu. int EMEA 2005 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Listen over de pågældende lægemiddelnavne fremgår af bilag I.(44-20) 74 18 84 00 Fax(44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http://www. emea. europa. eu©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Los principios activos de ADROVANCE son el alendronato y la vitamina D3.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged osteoklasterne, som er de celler.(44-20) 74 18 84 00 Fax(44-20) 74 18 84 47 E-mail: mail@emea. europa. eu http://www. emea. europa. eu©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged vacunas, comprimidos para lombrices, tratamientos contra pulgas y garrapatas.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Hvilken fordel viser undersøgelserne.(44-20) 74 18 84 00 Fax(44-20) 74 18 8613 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged simulado(es decir, exactamente el mismo procedimiento pero sin administrar Macugen ni utilizar aguja).
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 8613 E- mail: mail@ emea. eu. int http:// www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged I disse forsøg var brug Macugen/ skinbehandling.(44-20) 74 18 84 00 Fax(44-20) 75 23 71 29 E-mail: mail@emea. europa. eu http://www. emea. europa. eu©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged antes de emitir un dictamen, puede formular alguna otra pregunta(en el día 180) a la Empresa.
(44- 20) 74 18 84 00 Fax(44- 20) 75 23 71 29 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged afgiver en udtalelse, stille eventuelle supplerende spørgsmål(på dag 180) til firmaet.(44-20) 74 18 84 00 Fax(44-20) 74 18 86 13 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged La Comisión Europea convirtió el dictamen final en una Decisión el 21 de febrero de 2006.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 86 13 E- mail: mail@ emea. eu. int http:// www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Den endelige udtalelse blev konverteret til en afgørelse truffet af Europa- Kommissionen den 21. februar 2006.(44-20) 74 18 84 00 Fax(44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http://www. emea. europa. eu©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged No se han realizado estudios para comparar directamente la eficacia de Cyanokit con la de otros tratamientos en el ser humano.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged var indlagt på mistanke om cyanidforgiftning, og som fik Cyanokit.(44-20) 74 18 84 00 Fax(44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http://www. emea. europa. eu©EMEA 2008 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged metotrexato o sulfasalazina(otros medicamentos usados para tratar la artritis reumatoide).
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2008 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged(en virkningsløs behandling) eller med methotrexat eller sulphasalazin(andre lægemidler til behandling af rheumatoid arthritis).(44-20) 74 18 84 00 Fax(44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http://www. emea. europa. eu©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged AZILECT se ha examinado en tres estudios principales realizados en un total de 1.563 pacientes con enfermedad de Parkinson.
(44- 20) 74 18 84 00 Fax(44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http:// www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged AZILECT blev anvendt i tre hovedundersøgelser hos i alt 1 563 patienter med Parkinsons sygdom.
